Dr. Les Lilly
Dr. Lilly received his Undergraduate and Graduate training in Physiology and Pharmacology at the University of Toronto before completing his Medical education at McMaster University. He then completed Fellowships in Internal Medicine and Gastroenterology in Toronto. Following a Research Fellowship at the Brigham and Women’s Hospital in Boston in the laboratory of Dr. John Gollan, Dr. Lilly joined the Multi Organ Transplant Program at the Toronto General Hospital, which has one of North America’s largest liver transplant programs. He currently serves as the Medical Director of GI Transplantation as well as the Director of the Transplant Hepatology Fellowship Program. His main research interests include management and outcomes research in patients with viral hepatitis undergoing liver transplantation; he has also served as the Principal Investigator in several trials involving immunosuppression and antiviral medications in the transplant setting.
Dr. Nazia Selzner
Dr. Nazia Selzner is a Transplant Hepatologist in the Multi-Organ Transplant Program, Division of Gastroenterology, University Health Network, and Associate Professor of Medicine at the University of Toronto. Dr. Nazia Selzner is an Associate Scientist at the Institute for Medical Science (IMS) as well as at the Toronto General Research Institute (TGRI).
Dr. Selzner graduated from Medical School at the University of Paris VII, France. She completed her Gastroenterology and Hepatology training in 1998 at Clichy Liver Center, Paris, France. She completed her PhD in 2003 at the University of Paris VII, France, after four years of research fellowship at Duke University Medical Center, Durham, NC and at the University of Zurich, Switzerland. Following the completion of her PhD, she has performed a two years clinical fellowship in Liver Transplantation at the Multi-organ Transplant Program, at the University of Toronto. Her research interest is in the recurrence of chronic HCV infection post liver transplantation and mechanism of hepatic ischemia/reperfusion injury pertaining to fatty and aging liver. Dr Selzner’s main focus is developing protectives strategies against reperfusion of diseased/declined livers based on Ex Vivo Liver Perfusion platform.
Dr. Mamatha Bhat
Dr. Mamatha Bhat graduated from medical school at McGill University, followed by Internal Medicine and Gastroenterology residency training at the McGill University Health Centre. This was followed by a Resident Physician Health Research Career Training fellowship funded by the Fonds de Recherche du Quebec – Sante (FRQS), through which she completed an MSc in Experimental Medicine and the Royal College Clinician Investigator Program. Dr. Bhat went on to do a fellowship in Transplant Hepatology at Mayo Clinic in Rochester, Minnesota with mentorship from Dr. Gregory Gores, and is board-certified in Transplant Hepatology from the ABIM. She then continued research training with Dr. Nahum Sonenberg at McGill University through a Fellowship for Health Professionals from the Canadian Institutes for Health Research (CIHR), during which she studied mRNA translation in hepatocellular carcinoma. She was concomitantly a Staff Hepatologist at the Royal Victoria Hospital.
Dr. Bhat is currently a staff Hepatologist and clinician-scientist within the UHN Multi Organ Transplant Program and the UofT Gastroenterology Division, where she is employing innovative systems biology methods pertaining to malignant and metabolic complications after liver transplantation. Her research mandate is to develop a precision medicine program in hepatocellular carcinoma, non-alcoholic steatohepatitis, and liver regeneration in the context of liver transplantation.
Dr. Gary Levy
Professor Gary Levy is Professor of the Departments of Medicine, Immunology and Surgery at the University of Toronto, Canada. He served as the Director of the Multi Organ Transplant Program at the University Health Network and Director of the University of Toronto Transplant Institute until June 30, 2013.
Prof. Levy graduated from medical school at the University of Toronto in 1973, and undertook postdoctoral training in immunology at the Scripps Clinic and Research Foundation. In 1988, he was elected to be a member of the American Society for Clinical Investigation, and later organized and co-founded the Multi Organ Transplant Program at the University Health Network and the University of Toronto Transplantation Institute.
Prof. Levy’s research has focused on the immune-mediated mechanisms of organ injury due to viruses, alloantigens and xenoantigens. His research and clinical focus presently is on finding a way to achieve immunological tolerance, which could allow patients who have undergone solid organ transplant to discontinue their long term need for immunosuppression. He has published over 400 peer-reviewed articles, books and book chapters, and has trained over 60 masters and PhD students.
Prof. Levy has received numerous awards and lectureships throughout his career, including the William Goldie Price in Medicine, the Canadian Liver Foundation Commemorative Medal for the Queen’s Jubilee for his outstanding contribution to the study of liver disease, the Ivan T. Beck Lectureship from the Canadian Association of Gastroenterology, the Dr Richard Hunt Outstanding Service Award from the Canadian Digestive Health Foundation and the Williams Calne Lectureship from the British Association for the Study of the Liver. He is an Honorary Professor at Tongji University, Wuhan China. Prof. Levy is also a member of many national and international medical societies and committees, and was elected as a Fellow of the American Gastroenterological Association, the Canadian Association of Gastroenterology the American Association for Studies of Liver Disease and in 2015 was appointed to the Order of Ontario. He serves on the editorial boards of numerous journals including Transplantation, Liver Transplantation and the Journal of Immunology. He serves on the executive committee of the Institute of Medical Sciences, University of Toronto and is Medical Director and Head of the Scientific Advisory Board of Therapure Pharma Inc.
Dr. Keyur Patel
Dr. Keyur Patel received his Bachelor of Medicine degree from the University of Southampton, United Kingdom and completed his clinical fellowship in Internal Medicine/Gastroenterology and Hepatology in Perth, Western Australia. He completed a 3-year post-doctoral research fellowship in Clinical and Translational Research in viral hepatitis at Scripps Clinic and Research Foundation, San Diego, CA and Duke Clinical Research Institute, Durham NC. He was on faculty at Duke University 2004-2015, and an Associate Professor of Medicine with Tenure before moving to UHN Toronto in October 2015. His research Interests include clinical and translational research relating to host metabolic risk factors and mechanisms of fibrosis in viral hepatitis, along with the development of non-invasive markers of fibrosis, and the incorporation of functional genomic tools in the development of biomarkers of disease progression.
Dr. Mark Cattral
Dr. Mark Cattral is a Professor of Surgery, the Director of the Pancreas Transplantation Program, and a Sr. Scientist at the University Health Network, University of Toronto. Dr. Cattral’s laboratory is investigating dendritic cell biology and strategies to induce transplantation tolerance. Recent discoveries from his laboratory have contributed to the current understanding of dendritic cell ontogeny and function of immediate dendritic cell precursors.
Dr. Anand Ghanekar
Dr. Anand Ghanekar, MD PhD, is an attending surgeon in the Division of General Surgery at the University Health Network and Hospital for Sick Children, and Assistant Professor of Surgery at the University of Toronto. Dr. Ghanekar’s clinical practice is focused on abdominal organ transplantation in adults and children. He is Co-Director of the Kidney Transplant Program at the University Health Network. Dr. Ghanekar’s research laboratory studies stem cells in the context of hepatocellular carcinoma as well as developmental liver diseases.
Dr. David Grant
Dr. David Grant is Professor of Surgery at the University of Toronto where he is the Surgical Director, Transplantation, University Health Network and a staff surgeon at SickKids. He has published more than 250 papers and book chapters. Research interests include: small bowel transplantation, living donor liver transplantation, transplantation tolerance, and xenotransplantation. Dr. Grant performed the first liver-small bowel transplant in 1989. He is the Treasurer of the Canadian Transplant Society, past Chair of the Canadian Liver Transplant Section of the Canadian Transplant Society, and the past President of the International Intestine Transplant Society.
Dr. Paul Greig
Dr. Paul Greig is a Professor of Surgery at the University of Toronto where his academic and clinical focus is in Transplantation and Hepato-Pancreatico-Biliary Surgery. He is past President of the Canadian Society of Transplantation, former Chair of the Canadian Organ Replacement Register and former Director of the Multi-organ and Retrieval Programme of Toronto. Dr. Greig is the Co- Program Director of the Abdominal Organ Transplant Fellowship Program. His research interests are in liver transplantation, in particular disease-specific outcomes and living donor transplantation, and in HPB Surgical Oncology, in particular outcomes of the multidisciplinary management of hepatocellular carcinoma.
Dr. Ian McGilvray
Dr. Ian McGilvray studied medicine at McGill University, graduating in 1993. He entered the General Surgery training program at the University of Toronto that same year. During his residency he undertook graduate studies in Dr. Ori Rotstein’s laboratory, and obtained a PhD in Cell Biology. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. After a clinical fellowship in Transplantation and Hepatobiliary Surgery at Toronto General Hospital, he began his appointment at University Health Network in 2003. He is currently an Associate Professor in the Department of Surgery at the University of Toronto. His clinical focus is devoted to transplantation and to complex liver and pancreas oncology. His research centers on diseases of the liver, and includes research in viral hepatitis and nanomedicine.
Dr. Markus Selzner
Dr. Markus Selzner graduated from the Medical School at the University of Münster, Germany, in 1993 and started his residency at the Department of Surgery at the University of Cologne between 1994 and 1997. In 1997, he went to the Duke University Medical Center in North Carolina for a three-year research fellowship focusing on hepatic reperfusion injury. In 2000, Dr. Selzner continued his residency at the Department of Visceral and Transplantation Surgery at the University Hospital of Zurich, Switzerland, and was board certiﬁed in Surgery in 2002. He completed a fellowship in Liver/Pancreas Surgery and Liver Transplantation in Zürich between 2003 and 2005, and was appointed Assistant Professor of Surgery and Surgical Attending at the University of Zurich in 2003. Between 2005 and 2007 Dr. Selzner completed an Abdominal Organ Transplant Fellowship at the Toronto General Hospital in Toronto, Canada, and was appointed Clinical Associate in 2007. In July 2009 Dr. Selzner was appointed Associate Professor of Surgery at the University of Toronto.
Dr. Gonzalo Sapisochin
Dr. Gonzalo Sapisochin graduated from the Medical School at the Universidad Complutense de Madrid, Spain, in 2005 and started his general surgery residency at the Hospital Universitario Vall d´Hebron, Barcelona, Spain between 2006 and 2011. During his residency, he spent some periods of time in the USA, at Jackson Memorial, in Miami, and at University of California, in San Francisco. He also completed his doctoral thesis at the Universidad Autonoma of Barcelona, Spain in 2011.
From 2011 to 2013, he was employed as a staff surgeon at the Hospital Universitario Vall d´Hebron, in the Department of HPB Surgery and Transplantation.
In 2014, he started his Abdominal Transplant & HPB Surgical Oncology Fellowship at University of Toronto, and he finished his Fellowship in December, 2015. As of January 1, 2016, he became Staff Surgeon at Toronto General Hospital, in Toronto, Canada. In addition, he was appointed as Assistant Professor of the Department of Surgery, University of Toronto.